Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2021 | Thrombocytopenia in low-risk MDS

Valeria Santini, MD, University of Florence, Florence, Italy, discusses the incidence of thrombocytopenia in low-risk myelodysplastic syndromes (MDS), outlining strategies for management. This interview took place at the 16th International Congress on Myelodysplastic Syndromes, held virtually in 2021.